• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产生的 Shedding 受体片段可以被定向到蛋白酶体或溶酶体降解途径。

Shedding-generated Met receptor fragments can be routed to either the proteasomal or the lysosomal degradation pathway.

机构信息

CNRS UMR 8161, Institut de Biologie de Lille, Institut Pasteur de Lille, Université de Lille 1, Université de Lille 2, Lille cedex, France.

出版信息

Traffic. 2012 Sep;13(9):1261-72. doi: 10.1111/j.1600-0854.2012.01384.x. Epub 2012 Jun 20.

DOI:10.1111/j.1600-0854.2012.01384.x
PMID:22672335
Abstract

The receptor tyrosine kinase Met and its ligand, the hepatocyte growth factor/scatter factor, are essential for embryonic development, whereas deregulation of Met signaling pathways is associated with tumorigenesis and metastasis. The presenilin-regulated intramembrane proteolysis (PS-RIP) is involved in ligand-independent downregulation of Met. This proteolytic process involves shedding of the Met extracellular domain followed by γ-secretase cleavage, generating labile intracellular fragments degraded by the proteasome. We demonstrate here that upon shedding both generated Met N- and C-terminal fragments are degraded directly in the lysosome, with C-terminal fragments escaping γ-secretase cleavage. PS-RIP and lysosomal degradation are complementary, because their simultaneous inhibition induces synergistic accumulation of fragments. Met N-terminal fragments associate with the high-affinity domain of HGF/SF, confirming its decoy activity which could be reduced through their routing to the lysosome at the expense of extracellular release. Finally, the DN30 monoclonal antibody inducing Met shedding promotes receptor degradation through induction of both PS-RIP and the lysosomal pathway. Thus, we demonstrate that Met shedding initiates a novel lysosomal degradation which participates to ligand-independent downregulation of the receptor.

摘要

受体酪氨酸激酶 Met 及其配体肝细胞生长因子/分散因子对于胚胎发育至关重要,而 Met 信号通路的失调与肿瘤发生和转移有关。早老素调节的跨膜蛋白水解(PS-RIP)参与配体非依赖性的 Met 下调。这个蛋白水解过程涉及到 Met 细胞外结构域的脱落,随后是 γ-分泌酶的切割,产生不稳定的细胞内片段,被蛋白酶体降解。我们在这里证明,在脱落之后,产生的 Met N-和 C-末端片段都直接在溶酶体中降解,C-末端片段逃避 γ-分泌酶的切割。PS-RIP 和溶酶体降解是互补的,因为它们的同时抑制会导致片段的协同积累。Met N-末端片段与 HGF/SF 的高亲和力结构域结合,证实了其诱饵活性,这种活性可以通过将其路由到溶酶体而减少,代价是细胞外释放。最后,诱导 Met 脱落的 DN30 单克隆抗体通过诱导 PS-RIP 和溶酶体途径促进受体降解。因此,我们证明 Met 脱落启动了一种新的溶酶体降解,参与了受体的配体非依赖性下调。

相似文献

1
Shedding-generated Met receptor fragments can be routed to either the proteasomal or the lysosomal degradation pathway.产生的 Shedding 受体片段可以被定向到蛋白酶体或溶酶体降解途径。
Traffic. 2012 Sep;13(9):1261-72. doi: 10.1111/j.1600-0854.2012.01384.x. Epub 2012 Jun 20.
2
Down-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis.早老素依赖的调节性膜内蛋白水解作用导致间充质上皮转化受体酪氨酸激酶的下调。
Mol Biol Cell. 2009 May;20(9):2495-507. doi: 10.1091/mbc.e08-09-0969. Epub 2009 Mar 18.
3
Met degradation: more than one stone to shoot a receptor down.失活:一石二鸟,敲除受体。
FASEB J. 2012 Apr;26(4):1387-99. doi: 10.1096/fj.11-197723. Epub 2012 Jan 5.
4
Caspase cleavage of the MET receptor generates an HGF interfering fragment.MET受体的半胱天冬酶切割产生一种肝细胞生长因子干扰片段。
Biochem Biophys Res Commun. 2008 Mar 14;367(3):573-7. doi: 10.1016/j.bbrc.2007.12.177. Epub 2008 Jan 8.
5
The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.散射因子/肝细胞生长因子:c-met通路在人类胚胎中枢神经系统肿瘤恶性肿瘤中的作用
Cancer Res. 2005 Oct 15;65(20):9355-62. doi: 10.1158/0008-5472.CAN-05-1946.
6
Membrane-associated epithelial cell adhesion molecule is slowly cleaved by γ-secretase prior to efficient proteasomal degradation of its intracellular domain.膜相关上皮细胞黏附分子(Membrane-associated epithelial cell adhesion molecule)在其细胞内结构域被有效蛋白酶体降解之前,会被 γ-分泌酶缓慢切割。
J Biol Chem. 2019 Mar 1;294(9):3051-3064. doi: 10.1074/jbc.RA118.005874. Epub 2018 Dec 31.
7
The insulin-like growth factor 1 (IGF-1) receptor is a substrate for gamma-secretase-mediated intramembrane proteolysis.胰岛素样生长因子1(IGF-1)受体是γ-分泌酶介导的膜内蛋白水解的底物。
Biochem Biophys Res Commun. 2007 Jul 13;358(4):1136-41. doi: 10.1016/j.bbrc.2007.05.062. Epub 2007 May 21.
8
Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.正常及恶性细胞中肝细胞生长因子受体的结构、生物合成及生化特性
EXS. 1993;65:131-65.
9
The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.格尔德霉素是肝细胞生长因子/分散因子-甲硫氨酸-尿激酶型纤溶酶原激活剂-纤溶酶蛋白水解网络的强效抑制剂。
Cancer Res. 2000 Jan 15;60(2):342-9.
10
Degradation of the GAB1 adaptor by the ubiquitin-proteasome pathway hampers HGF/SF-MET signaling.GAB1 衔接子通过泛素-蛋白酶体途径降解,阻碍了 HGF/SF-MET 信号。
Biochem Biophys Res Commun. 2011 Aug 12;411(4):780-5. doi: 10.1016/j.bbrc.2011.07.024. Epub 2011 Jul 18.

引用本文的文献

1
Tigilanol Tiglate-Induced Changes in Secretome Profiles Alter C-Met Phosphorylation and Cell Surface Protein Expression in H357 Head and Neck Cancer Cells.替吉奥醇替吉奥诱导的分泌组谱变化改变了 H357 头颈癌细胞中 C-Met 的磷酸化和细胞表面蛋白表达。
Cells. 2024 Jun 5;13(11):982. doi: 10.3390/cells13110982.
2
Manipulating PTPRD function with ectodomain antibodies.利用外域抗体来操控 PTPRD 功能。
Genes Dev. 2023 Aug 1;37(15-16):743-759. doi: 10.1101/gad.350713.123. Epub 2023 Sep 5.
3
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers.
hOA-DN30:一种高效的人源化单臂 MET 抗体,可诱导“MET 成瘾”癌症缓解。
J Exp Clin Cancer Res. 2022 Mar 29;41(1):112. doi: 10.1186/s13046-022-02320-6.
4
The Occurrence of MET Ectodomain Shedding in Oral Cancer and Its Potential Impact on the Use of Targeted Therapies.MET外显子脱落现象在口腔癌中的发生及其对靶向治疗应用的潜在影响。
Cancers (Basel). 2022 Mar 15;14(6):1491. doi: 10.3390/cancers14061491.
5
G-749 Promotes Receptor Tyrosine Kinase TYRO3 Degradation and Induces Apoptosis in Both Colon Cancer Cell Lines and Xenograft Mouse Models.G-749促进受体酪氨酸激酶TYRO3降解并在结肠癌细胞系和异种移植小鼠模型中诱导细胞凋亡。
Front Pharmacol. 2021 Oct 14;12:730241. doi: 10.3389/fphar.2021.730241. eCollection 2021.
6
Proteasome Inhibitors Diminish c-Met Expression and Induce Cell Death in Non-Small Cell Lung Cancer Cells.蛋白酶体抑制剂可降低非小细胞肺癌细胞中 c-Met 的表达并诱导其死亡。
Oncol Res. 2020 Dec 10;28(5):497-507. doi: 10.3727/096504020X15929939001042. Epub 2020 Jun 24.
7
ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors.免疫 PET 预测对转移性胰腺癌对 MET 激酶抑制剂耐药模型的放射性配体治疗的反应。
Theranostics. 2020 Jan 1;10(1):151-165. doi: 10.7150/thno.37098. eCollection 2020.
8
Thiosemicarbazones suppress expression of the c-Met oncogene by mechanisms involving lysosomal degradation and intracellular shedding.缩氨基硫脲通过涉及溶酶体降解和细胞内脱落的机制抑制c-Met癌基因的表达。
J Biol Chem. 2020 Jan 10;295(2):481-503. doi: 10.1074/jbc.RA119.011341. Epub 2019 Nov 19.
9
Proteolytic cleavages of MET: the divide-and-conquer strategy of a receptor tyrosine kinase.MET 的蛋白水解切割:受体酪氨酸激酶的分而治之策略。
BMB Rep. 2019 Apr;52(4):239-249. doi: 10.5483/BMBRep.2019.52.4.024.
10
Hypoxia leads to decreased autophosphorylation of the MET receptor but promotes its resistance to tyrosine kinase inhibitors.缺氧导致MET受体的自磷酸化减少,但增强其对酪氨酸激酶抑制剂的抗性。
Oncotarget. 2018 Jun 5;9(43):27039-27058. doi: 10.18632/oncotarget.25472.